Mumbai-based startup Invex Health has developed an Oral Fluid-Based HIV Self-Test, a ground-breaking product currently undergoing validation in India.

Developing this test is considerably more challenging than traditional blood-based tests, with only one company worldwide having achieved commercialisation with WHO pre-qualification. 

In a significant stride towards expanding its therapeutic offerings, Invex Health has recently acquired the global licensing rights for a patented product addressing Psoriasis.

By manufacturing this product in India and gradually making it available in various markets at an affordable price, it can been revolutionising the treatment landscape for individuals affected by Psoriasis. This strategic move underscores the company's commitment to innovation in patient care.

Invex Health is also expanding its market by offering natural OTC antidepressant and mood boosters, which can be used by many people searching for better and safer options to deal with multiple mood disorders.

The startup is further establishing itself and creating the largest platform for cancer therapy in India. Through strategic collaborations with renowned oncologists, hospitals, and cancer treatment centres, the company ensures timely access to advanced cancer treatments. .